Meridian Bioscience Inc. (NASDAQ:VIVO) will be hosting a conference call at 10:00 AM eastern time on 7th August 2020, to discuss its 3Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.meridianbioscience.com
Earnings Expectation
Meridian Bioscience Inc. is reporting third quarter earnings results on Friday 7th August 2020, before market open. The consensus estimates from Thomson Reuters are income of $ 0.23 per share from $ 66.04 million in revenue. For the full year, analysts predict revenues of $ 235.58 million, while looking forward to income of $ 0.75 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 230.00 million ~ $ 236.00 million, where as bottomline are predicted in a range of $ 0.70 ~ $ 0.75 per share
Click Here For More Historical Outlooks Of Meridian Bioscience Inc.
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for various gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms and technologies, including isothermal DNA amplification under the Alethia brand; rapid immunoassays, a single-use immunoassays under the ImmunoCard and ImmunoCard STAT!
